Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medicines
Safety Notices
My HPRA:
Login
Register
About Us
Medicines
COVID-19 vaccines and treatments
Our Role
Medicines Information
Safety Information
Safety Notices
Quality Information
Regulatory Information
News & Events
Special Topics
Emergency Medicines
Emergency Contact Details
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Flixonase Allergy Relief (fluticasone propionate) - Important Safety Information from GlaxoSmithKline Consumer Healthcare (Ireland) Limited as approved by the Irish Medicines Board
Notice type:
3rd Party Publications
Date:
18/12/2013
Problem Or Issue:
Important Safety Information communication from GlaxoSmithKline Consumer Healthcare (Ireland) Limited on the restriction of use to adults (aged over 18 years) only due to growth velocity reduction concerns in children with Flixonase Allergy Relief (fluticasone propionate).
Important Safety Information - Flixonase Allergy Relief (fluticasone propionate)
« Back
Date Printed: 19/05/2024